The search results don't specifically address Dupilumab's availability in the UK. However, Dupilumab (Dupixent) was the first FDA-approved biologic medication for treating EoE in 2022. It's administered as a weekly injection under the skin and has shown effectiveness in patients who haven't responded to other therapies. The medication is approved for adults and children ages 1 year and older who weigh at least 33 pounds (15 kilograms). Common side effects include injection site reactions and upper respiratory tract infections. It's recommended to discuss this treatment option with your healthcare provider to understand availability in your region.